{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:12:26Z","timestamp":1783977146094,"version":"3.55.0"},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T00:00:00Z","timestamp":1531958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T00:00:00Z","timestamp":1531958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00296-018-4111-4","type":"journal-article","created":{"date-parts":[[2018,7,19]],"date-time":"2018-07-19T06:28:33Z","timestamp":1531981713000},"page":"1587-1600","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Rheumatology science and practice in India"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5035-7396","authenticated-orcid":false,"given":"Durga Prasanna","family":"Misra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0813-1243","authenticated-orcid":false,"given":"Aman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4508-1233","authenticated-orcid":false,"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,19]]},"reference":[{"key":"4111_CR1","unstructured":"World population by continent (Internet). http:\/\/worldpopulationreview.com\/continents\/. Accessed 23 Dec 2017"},{"key":"4111_CR2","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1016\/s0140-6736(17)32804-0","volume":"390","author":"L Dandona","year":"2017","unstructured":"Dandona L et al (2017) Nations within a nation: variations in epidemiological transition across the states of India, 1990\u20132016 in the Global Burden of Disease Study. Lancet 390:2437\u20132460. https:\/\/doi.org\/10.1016\/s0140-6736(17)32804-0","journal-title":"Lancet"},{"key":"4111_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.injr.2015.04.002","volume":"10","author":"A Chopra","year":"2015","unstructured":"Chopra A (2015) Disease burden of rheumatic diseases in India: COPCORD perspective. Indian J Rheumatol 10:70\u201377. https:\/\/doi.org\/10.1016\/j.injr.2015.04.002","journal-title":"Indian J Rheumatol"},{"key":"4111_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nrrheum.2014.182","volume":"11","author":"R Handa","year":"2015","unstructured":"Handa R (2015) Rheumatology in India\u2014quo vadis? Nat Rev Rheumatol 11:183\u2013188. https:\/\/doi.org\/10.1038\/nrrheum.2014.182","journal-title":"Nat Rev Rheumatol"},{"key":"4111_CR5","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3346\/jkms.2016.31.7.1013","volume":"31","author":"DP Misra","year":"2016","unstructured":"Misra DP, Agarwal V, Negi VS (2016) Rheumatology in India: a bird\u2019s eye view on organization, epidemiology, training programs and publications. J Korean Med Sci 31:1013\u20131019. https:\/\/doi.org\/10.3346\/jkms.2016.31.7.1013","journal-title":"J Korean Med Sci"},{"key":"4111_CR6","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1093\/rheumatology\/keu306","volume":"54","author":"T Gibson","year":"2015","unstructured":"Gibson T (2015) Rheumatology in India and Pakistan today. Rheumatology 54:753\u2013754. https:\/\/doi.org\/10.1093\/rheumatology\/keu306","journal-title":"Rheumatology"},{"key":"4111_CR7","unstructured":"Healthcare in India (Internet). http:\/\/assets.ce.columbia.edu\/pdf\/actu\/actu-india.pdf. Accessed 23 Dec 2017"},{"key":"4111_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00296-018-3996-2","volume":"38","author":"DP Misra","year":"2018","unstructured":"Misra DP, Sharma A, Agarwal V (2018) Guidelines for management of rheumatic diseases in developing countries from basics to real-world situation: relevance, need, and processes for development. Rheumatol Int 38:549\u2013556. https:\/\/doi.org\/10.1007\/s00296-018-3996-2","journal-title":"Rheumatol Int"},{"key":"4111_CR9","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31:1409\u20131417. https:\/\/doi.org\/10.1007\/s00296-011-1999-3","journal-title":"Rheumatol Int"},{"key":"4111_CR10","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","volume":"76","author":"JS Smolen","year":"2017","unstructured":"Smolen JS, Landew\u00e9 R, Bijlsma J et al (2017) EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Ann Rheum Dis 76:960\u2013977","journal-title":"Ann Rheum Dis"},{"key":"4111_CR11","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s10067-015-2980-4","volume":"34","author":"KK Roshique","year":"2015","unstructured":"Roshique KK, Ravindran V (2015) Efficacy and safety of a biosimilar rituximab in biologic naive patients with active rheumatoid arthritis. Clin Rheumatol 34:1289\u20131292. https:\/\/doi.org\/10.1007\/s10067-015-2980-4","journal-title":"Clin Rheumatol"},{"key":"4111_CR12","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s10067-016-3332-8","volume":"35","author":"M Bhati","year":"2016","unstructured":"Bhati M, Bandyopadhyay S (2016) Efficacy and safety of an anti-CD20 monoclonal antibody (Reditux\u2122) for the treatment of patients with moderate to severe rheumatoid arthritis following the failure of conventional synthetic disease-modifying anti-rheumatic drugs. Clin Rheumatol 35:1931\u20131935. https:\/\/doi.org\/10.1007\/s10067-016-3332-8","journal-title":"Clin Rheumatol"},{"key":"4111_CR13","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1007\/s10067-016-3283-0","volume":"35","author":"AN Malaviya","year":"2016","unstructured":"Malaviya AN, Gogia SB (2016) Treatment of rheumatoid arthritis (RA) in India\u2014how and by whom: results from a speciality clinic\u2014use of low-dose methotrexate (MTX) was inexplicably suboptimal. Clin Rheumatol 35:2163\u20132173","journal-title":"Clin Rheumatol"},{"key":"4111_CR14","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10067-016-3398-3","volume":"36","author":"AN Malaviya","year":"2017","unstructured":"Malaviya AN (2017) Methotrexate intolerance in the treatment of rheumatoid arthritis (RA): effect of adding caffeine to the management regimen. Clin Rheumatol 36:279\u2013285. https:\/\/doi.org\/10.1007\/s10067-016-3398-3","journal-title":"Clin Rheumatol"},{"key":"4111_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0973-3698(10)60020-9","volume":"2","author":"BJ Paul","year":"2007","unstructured":"Paul BJ, Thachil EJ, Jayachandran NV, Radhakrishnan S (2007) Clinical efficacy and adverse effects of weekly single dose leflunomide in refractory rheumatoid arthritis. Indian J Rheumatol 2:3\u20137. https:\/\/doi.org\/10.1016\/S0973-3698(10)60020-9","journal-title":"Indian J Rheumatol"},{"key":"4111_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1756-185X.2011.01684.x","volume":"14","author":"K Gopinath","year":"2011","unstructured":"Gopinath K, Danda D (2011) Supplementation of 1,25 dihydroxy vitamin D3 in patients with treatment naive early rheumatoid arthritis: a randomised controlled trial. Int J Rheum Dis 14:332\u2013339. https:\/\/doi.org\/10.1111\/j.1756-185X.2011.01684.x","journal-title":"Int J Rheum Dis"},{"key":"4111_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00296-002-0186-y","volume":"22","author":"S Pandya","year":"2002","unstructured":"Pandya S, Aggarwal A, Misra R (2002) Methotrexate twice weekly vs once weekly in rheumatoid arthritis: a pilot double-blind, controlled study. Rheumatol Int 22:1\u20134","journal-title":"Rheumatol Int"},{"key":"4111_CR18","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.12910","author":"P Dhaon","year":"2016","unstructured":"Dhaon P, Das SK, Srivastava R, Agarwal G, Asthana A (2016) Oral Methotrexate in split dose weekly versus oral or parenteral methotrexate once weekly in rheumatoid arthritis: a short-term study. Int J Rheum Dis. https:\/\/doi.org\/10.1111\/1756-185x.12910","journal-title":"Int J Rheum Dis"},{"key":"4111_CR19","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/1756-185x.13004","volume":"20","author":"S Ajmani","year":"2017","unstructured":"Ajmani S, Preet Singh Y, Prasad S et al (2017) Methotrexate-induced pancytopenia: a case series of 46 patients. Int J Rheum Dis 20:846\u2013851. https:\/\/doi.org\/10.1111\/1756-185x.13004","journal-title":"Int J Rheum Dis"},{"key":"4111_CR20","first-page":"1365","volume":"27","author":"A Chopra","year":"2000","unstructured":"Chopra A, Lavin P, Patwardhan B, Chitre D (2000) Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis. J Rheumatol 27:1365\u20131372","journal-title":"J Rheumatol"},{"key":"4111_CR21","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10067-011-1809-z","volume":"31","author":"A Chopra","year":"2012","unstructured":"Chopra A, Saluja M, Tillu G et al (2012) Comparable efficacy of standardized ayurveda formulation and hydroxychloroquine sulfate (HCQS) in the treatment of rheumatoid arthritis (RA): a randomized investigator-blind controlled study. Clin Rheumatol 31:259\u2013269","journal-title":"Clin Rheumatol"},{"key":"4111_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-4-118","author":"S Telles","year":"2011","unstructured":"Telles S, Naveen KV, Gaur V, Balkrishna A (2011) Effect of one week of yoga on function and severity in rheumatoid arthritis. BMC Res Notes. https:\/\/doi.org\/10.1186\/1756-0500-4-118","journal-title":"BMC Res Notes"},{"key":"4111_CR23","doi-asserted-by":"publisher","first-page":"8284","DOI":"10.1073\/pnas.1605635113","volume":"113","author":"FA Koopman","year":"2016","unstructured":"Koopman FA, Chavan SS, Miljko S et al (2016) Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc Natl Acad Sci USA 113:8284\u20138289. https:\/\/doi.org\/10.1073\/pnas.1605635113","journal-title":"Proc Natl Acad Sci USA"},{"key":"4111_CR24","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fpsyt.2018.00044","volume":"9","author":"S Breit","year":"2018","unstructured":"Breit S, Kupferberg A, Rogler G, Hasler G (2018) Vagus nerve as modulator of the brain\u2013gut axis in psychiatric and inflammatory disorders. Front Psychiatry 9:44. https:\/\/doi.org\/10.3389\/fpsyt.2018.00044","journal-title":"Front Psychiatry"},{"key":"4111_CR25","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","volume":"76","author":"D van der Heijde","year":"2017","unstructured":"van der Heijde D, Ramiro S, Landew\u00e9 R et al (2017) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 76:978\u2013991","journal-title":"Ann Rheum Dis"},{"key":"4111_CR26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/1756-185X.13124","volume":"21","author":"S Khanna Sharma","year":"2018","unstructured":"Khanna Sharma S, Kadiyala V, Naidu G, Dhir V (2018) A randomized controlled trial to study the efficacy of sulfasalazine for axial disease in ankylosing spondylitis. Int J Rheum Dis 21:308\u2013314. https:\/\/doi.org\/10.1111\/1756-185X.13124","journal-title":"Int J Rheum Dis"},{"key":"4111_CR27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s10067-011-1723-4","volume":"30","author":"P Sandhya","year":"2011","unstructured":"Sandhya P, Danda D, Mathew J, Gattani A (2011) Outcome of patients with seronegative spondyloarthritis continuing sulphasalazine and methotrexate after a short course of infliximab therapy\u2014experience from a tertiary care teaching hospital in South India. Clin Rheumatol 30:997\u20131001. https:\/\/doi.org\/10.1007\/s10067-011-1723-4","journal-title":"Clin Rheumatol"},{"key":"4111_CR28","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1007\/s10067-017-3726-2","volume":"36","author":"AM Nair","year":"2017","unstructured":"Nair AM, Sandhya P, Yadav B, Danda D (2017) TNF\u03b1 blockers followed by continuation of sulfasalazine and methotrexate combination: a retrospective study on cost saving options of treatment in spondyloarthritis. Clin Rheumatol 36:2243\u20132251. https:\/\/doi.org\/10.1007\/s10067-017-3726-2","journal-title":"Clin Rheumatol"},{"key":"4111_CR29","first-page":"883","volume":"51","author":"G Santra","year":"2010","unstructured":"Santra G, Sarkar RN, Phaujdar S, Banerjee S, Siddhanta S (2010) Assessment of the efficacy of pamidronate in ankylosing spondylitis: an open prospective trial. Singap Med J 51:883\u2013887","journal-title":"Singap Med J"},{"key":"4111_CR30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0973-3698(11)60004-6","volume":"5","author":"S Shukla","year":"2010","unstructured":"Shukla S, Misra R, Agarwal V (2010) Pulse pamidronate therapy in NSAID refractory ankylosing spondylitis. Is it effective?\u2014An open label study. Indian J Rheumatol 5:171\u2013175. https:\/\/doi.org\/10.1016\/S0973-3698(11)60004-6","journal-title":"Indian J Rheumatol"},{"key":"4111_CR31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1136\/ard.2005.041392","volume":"65","author":"R Grover","year":"2006","unstructured":"Grover R, Shankar S, Aneja R et al (2006) Treatment of ankylosing spondylitis with pamidronate: an open label study. Ann Rheum Dis 65:688\u2013689. https:\/\/doi.org\/10.1136\/ard.2005.041392","journal-title":"Ann Rheum Dis"},{"key":"4111_CR32","first-page":"193","volume":"55","author":"AN Malaviya","year":"2007","unstructured":"Malaviya AN, Kapoor S, Garg S, Ahmad I, Raja RR (2007) A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate. J Assoc Physicians India 55:193\u2013197","journal-title":"J Assoc Physicians India"},{"key":"4111_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1479-8077.2006.00181.x","volume":"9","author":"R Handa","year":"2006","unstructured":"Handa R, Misra R, Chaturvedi VP et al (2006) Guidelines for tuberculosis prophylaxis during anti-tumour necrosis factor-\u03b1 treatment: Indian Rheumatology Association. APLAR J Rheumatol 9:181\u2013183. https:\/\/doi.org\/10.1111\/j.1479-8077.2006.00181.x","journal-title":"APLAR J Rheumatol"},{"key":"4111_CR34","unstructured":"CDC treatment regimens for latent tuberculosis. https:\/\/www.cdc.gov\/tb\/topic\/treatment\/ltbi.htm. Accessed 22 Jun 2018"},{"key":"4111_CR35","first-page":"78","volume":"13","author":"R Grover","year":"2005","unstructured":"Grover R, Kapoor S, Marwaha V et al (2005) Clinical experience with infliximab in spondyloarthropathy: an open label study on fourteen patients. J Indian Rheumatol Assoc 13:78\u201382","journal-title":"J Indian Rheumatol Assoc"},{"key":"4111_CR36","doi-asserted-by":"crossref","unstructured":"(2011) Risk of infection during biologic therapy in rheumatic diseases: five years experience in a tertiary care hospital. Indian J Rheumatol 6:113\u2013114","DOI":"10.1016\/S0973-3698(11)60041-1"},{"key":"4111_CR37","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0973-3698(11)60040-X","volume":"6","author":"A Malaviya","year":"2011","unstructured":"Malaviya A, Haroon N (2011) Infections associated with the use of biologic response modifiers in rheumatic diseases: a critical appraisal. Indian J Rheumatol 6:99\u2013112","journal-title":"Indian J Rheumatol"},{"key":"4111_CR38","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1136\/annrheumdis-2012-202745","volume":"72","author":"L Fernandes","year":"2013","unstructured":"Fernandes L, Hagen KB, Bijlsma JWJ et al (2013) EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis 72:1125\u20131135","journal-title":"Ann Rheum Dis"},{"key":"4111_CR39","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1002\/art.10455","volume":"47","author":"SK Das","year":"2002","unstructured":"Das SK, Ramakrishnan S, Mishra K et al (2002) A randomized controlled trial to evaluate the slow-acting symptom-modifying effects of colchicine in osteoarthritis of the knee: a preliminary report. Arthritis Rheum 47:280\u2013284","journal-title":"Arthritis Rheum"},{"key":"4111_CR40","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1053\/joca.2002.0516","volume":"10","author":"SK Das","year":"2002","unstructured":"Das SK, Mishra K, Ramakrishnan S et al (2002) A randomized controlled trial to evaluate the slow-acting symptom modifying effects of a regimen containing colchicine in a subset of patients with osteoarthritis of the knee. Osteoarthritis Cartil 10:247\u2013252. https:\/\/doi.org\/10.1053\/joca.2002.0516","journal-title":"Osteoarthritis Cartil"},{"key":"4111_CR41","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s13075-016-1195-7","volume":"18","author":"PK Gupta","year":"2016","unstructured":"Gupta PK, Chullikana A, Rengasamy M et al (2016) Efficacy and safety of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells (Stempeucel\u00ae): preclinical and clinical trial in osteoarthritis of the knee joint. Arthritis Res Ther 18:301. https:\/\/doi.org\/10.1186\/s13075-016-1195-7","journal-title":"Arthritis Res Ther"},{"key":"4111_CR42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.5414\/CPP48429","volume":"48","author":"P Sancheti","year":"2010","unstructured":"Sancheti P, Hardikar M, Karne N et al (2010) A multicentric, randomized, comparative clinical trial to evaluate the efficacy and safety of S-etodolac in the treatment of osteoarthritis in Indian patients. Int J Clin Pharmacol Ther 48:429\u2013434. https:\/\/doi.org\/10.5414\/CPP48429","journal-title":"Int J Clin Pharmacol Ther"},{"key":"4111_CR43","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jpain.2010.10.013","volume":"12","author":"A Pareek","year":"2011","unstructured":"Pareek A, Chandurkar N, Gupta A et al (2011) Efficacy and safety of aceclofenac-CR and aceclofenac in the treatment of knee osteoarthritis: a 6-week, comparative, randomized, multicentric, double-blind study. J Pain 12:546\u2013553. https:\/\/doi.org\/10.1016\/j.jpain.2010.10.013","journal-title":"J Pain"},{"key":"4111_CR44","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1517\/14656566.2011.566867","volume":"12","author":"A Pareek","year":"2011","unstructured":"Pareek A, Gupta AK, Chandurkar NB et al (2011) Zaltoprofen, a noninferior alternative to diclofenac for the treatment of primary knee osteoarthritis\u2014a comparative evaluation of efficacy and safety in a 4-week, multicentric, randomized, double-blind, double-dummy trial. Expert Opin Pharmacother 12:1007\u20131015. https:\/\/doi.org\/10.1517\/14656566.2011.566867","journal-title":"Expert Opin Pharmacother"},{"key":"4111_CR45","first-page":"50","volume":"3","author":"Srikanth","year":"2012","unstructured":"Srikanth, Shah HM, Shivamurthy MC, Niveditha (2012) A comparative study of efficacy and tolerability of dexketoprofen trometamol versus diclofenac sodium in the symptomatic treatment of knee osteoarthritis. Pharmacologyonline 3:50\u201357","journal-title":"Pharmacologyonline"},{"key":"4111_CR46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.4103\/ijp.IJP_245_16","volume":"49","author":"Y Garg","year":"2017","unstructured":"Garg Y, Singh J, Sohal HS, Gore R, Kumar A (2017) Comparison of clinical effectiveness and safety of newer nonsteroidal anti-inflammatory drugs in patients of osteoarthritis of knee joint: a randomized, prospective, open-label parallel-group study. Indian J Pharmacol 49:383\u2013389. https:\/\/doi.org\/10.4103\/ijp.IJP_245_16","journal-title":"Indian J Pharmacol"},{"key":"4111_CR47","doi-asserted-by":"publisher","first-page":"FC06","DOI":"10.7860\/JCDR\/2017\/27644.10759","volume":"11","author":"RK Tripathi","year":"2017","unstructured":"Tripathi RK, Vaidya PH, Raote S et al (2017) Efficacy and safety evaluation of myostaal forte, a polyherbal formulation, in treatment of knee osteoarthritis: a randomised controlled pilot study. J Clin Diagn Res 11:FC06\u2013FC10. https:\/\/doi.org\/10.7860\/JCDR\/2017\/27644.10759","journal-title":"J Clin Diagn Res"},{"key":"4111_CR48","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/0253-7613.75674","volume":"43","author":"AK Gupta","year":"2011","unstructured":"Gupta AK, Acharya K, Sancheti PS, Joshi RS (2011) A double-blind, randomized, multicentric, placebo-controlled clinical trial of antarth, a phytomedicine, in the treatment of osteoarthritis. Indian J Pharmacol 43:69\u201372. https:\/\/doi.org\/10.4103\/0253-7613.75674","journal-title":"Indian J Pharmacol"},{"key":"4111_CR49","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1093\/rheumatology\/kes414","volume":"52","author":"A Chopra","year":"2013","unstructured":"Chopra A, Saluja M, Tillu G et al (2013) Ayurvedic medicine offers a good alternative to glucosamine and celecoxib in the treatment of symptomatic knee osteoarthritis: a randomized, double-blind, controlled equivalence drug trial. Rheumatology 52:1408\u20131417. https:\/\/doi.org\/10.1093\/rheumatology\/kes414","journal-title":"Rheumatology"},{"key":"4111_CR50","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/096120339700600903","volume":"6","author":"AN Malaviya","year":"1997","unstructured":"Malaviya AN, Chandrasekaran AN, Kumar A, Shamar PN (1997) Occasional series\u2014lupus around the world systemic lupus erythematosus in India. Lupus 6:690\u2013700. https:\/\/doi.org\/10.1177\/096120339700600903","journal-title":"Lupus"},{"key":"4111_CR51","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","volume":"71","author":"GK Bertsias","year":"2012","unstructured":"Bertsias GK, Tektonidou M, Amoura Z et al (2012) Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 71:1771\u20131782","journal-title":"Ann Rheum Dis"},{"key":"4111_CR52","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/rheumatology\/kex286","volume":"57","author":"C Gordon","year":"2018","unstructured":"Gordon C, Amissah-Arthur MB, Gayed M et al (2018) The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults. Rheumatology 57:e1\u2013e45. https:\/\/doi.org\/10.1093\/rheumatology\/kex286","journal-title":"Rheumatology"},{"key":"4111_CR53","first-page":"101","volume":"96","author":"AN Malaviya","year":"1992","unstructured":"Malaviya AN, Singh RR, Sindhwani R et al (1992) Intermittent intravenous pulse cyclophosphamide treatment in systemic lupus erythematosus. Indian J Med Res 96:101\u2013108","journal-title":"Indian J Med Res"},{"key":"4111_CR54","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/ki.2015.318","volume":"89","author":"M Rathi","year":"2016","unstructured":"Rathi M, Goyal A, Jaryal A et al (2016) Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis. Kidney Int 89:235\u2013242. https:\/\/doi.org\/10.1038\/ki.2015.318","journal-title":"Kidney Int"},{"key":"4111_CR55","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s00296-018-3995-3","volume":"38","author":"S Mehra","year":"2018","unstructured":"Mehra S, Usdadiya JB, Jain VK, Misra DP, Negi VS (2018) Comparing the efficacy of low-dose vs high-dose cyclophosphamide regimen as induction therapy in the treatment of proliferative lupus nephritis: a single center study. Rheumatol Int 38:557\u2013568. https:\/\/doi.org\/10.1007\/s00296-018-3995-3","journal-title":"Rheumatol Int"},{"key":"4111_CR56","doi-asserted-by":"publisher","first-page":"35","DOI":"10.4103\/ijn.IJN_2_16","volume":"28","author":"M Sahay","year":"2018","unstructured":"Sahay M, Saivani Y, Ismal K, Vali P (2018) Mycophenolate versus cyclophosphamide for lupus nephritis. Indian J Nephrol 28:35\u201340. https:\/\/doi.org\/10.4103\/ijn.IJN_2_16","journal-title":"Indian J Nephrol"},{"key":"4111_CR57","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/0140-6736(92)92292-N","volume":"340","author":"DT Boumpas","year":"1992","unstructured":"Boumpas DT, Austin HA III, Vaughn EM et al (1992) Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 340:741\u2013745","journal-title":"Lancet"},{"key":"4111_CR58","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10067-015-3079-7","volume":"35","author":"A Kansal","year":"2016","unstructured":"Kansal A, Tripathi D, Rai MK, Agarwal V (2016) Persistent expression and function of P-glycoprotein on peripheral blood lymphocytes identifies corticosteroid resistance in patients with systemic lupus erythematosus. Clin Rheumatol 35:341\u2013349. https:\/\/doi.org\/10.1007\/s10067-015-3079-7","journal-title":"Clin Rheumatol"},{"issue":"suppl 10","key":"4111_CR59","first-page":"2787","volume":"69","author":"V Gupta","year":"2017","unstructured":"Gupta V, Edavalath S, Rai MK et al (2017) Tacrolimus induces remission in refractory and relapsing lupus nephritis by decreasing P-glycoprotein expression and function on peripheral blood lymphocytes (abstract). Arthritis Rheumatol 69(suppl 10):2787\u20132788","journal-title":"Arthritis Rheumatol"},{"key":"4111_CR60","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1007\/s10067-017-3775-6","volume":"36","author":"N Gupta","year":"2017","unstructured":"Gupta N, Ganpati A, Mandal S et al (2017) Mycophenolate mofetil and deflazacort combination in neuropsychiatric lupus: a decade of experience from a tertiary care teaching hospital in southern India. Clin Rheumatol 36:2273\u20132279. https:\/\/doi.org\/10.1007\/s10067-017-3775-6","journal-title":"Clin Rheumatol"},{"key":"4111_CR61","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/rheumatology\/kev097","volume":"54","author":"S Kommireddy","year":"2015","unstructured":"Kommireddy S, Bhyravavajhala S, Kurimeti K et al (2015) Pulmonary arterial hypertension in systemic lupus erythematosus may benefit by addition of immunosuppression to vasodilator therapy: an observational study. Rheumatology 54:1673\u20131679. https:\/\/doi.org\/10.1093\/rheumatology\/kev097","journal-title":"Rheumatology"},{"key":"4111_CR62","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1093\/rheumatology\/keq291","volume":"49","author":"PD Shenoy","year":"2010","unstructured":"Shenoy PD, Kumar S, Jha LK et al (2010) Efficacy of tadalafil in secondary Raynaud\u2019s phenomenon resistant to vasodilator therapy: a double-blind randomized cross-over trial. Rheumatology 49:2420\u20132428. https:\/\/doi.org\/10.1093\/rheumatology\/keq291","journal-title":"Rheumatology"},{"key":"4111_CR63","unstructured":"Agarwal V, Ghosh P, Sharma A et al Efficacy of tadalafil in Raynaud\u2019s phenomenon secondary to systemic sclerosis: a double blind randomized placebo controlled parallel group multicentric study (abstract). Arthritis Rheum 62 (suppl 10):2086"},{"key":"4111_CR64","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","volume":"76","author":"O Kowal-Bielecka","year":"2017","unstructured":"Kowal-Bielecka O, Fransen J, Avouac J et al (2017) Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis 76:1327\u20131339","journal-title":"Ann Rheum Dis"},{"key":"4111_CR65","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/j.1756-185X.2009.01417.x","volume":"12","author":"A Wanchu","year":"2009","unstructured":"Wanchu A, Suryanaryana BS, Sharma S, Sharma A, Bambery P (2009) High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study. Int J Rheum Dis 12:239\u2013242. https:\/\/doi.org\/10.1111\/j.1756-185X.2009.01417.x","journal-title":"Int J Rheum Dis"},{"key":"4111_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1015-0","author":"PD Shenoy","year":"2016","unstructured":"Shenoy PD, Bavaliya M, Sashidharan S, Nalianda K, Sreenath S (2016) Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis. Arthritis Res Ther. https:\/\/doi.org\/10.1186\/s13075-016-1015-0","journal-title":"Arthritis Res Ther"},{"key":"4111_CR67","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s00296-012-2466-5","volume":"33","author":"U Kumar","year":"2013","unstructured":"Kumar U, Gokhle SS, Sreenivas V, Kaur S, Misra D (2013) Prospective, open-label, uncontrolled pilot study to study safety and efficacy of sildenafil in systemic sclerosis-related pulmonary artery hypertension and cutaneous vascular complications. Rheumatol Int 33:1047\u20131052. https:\/\/doi.org\/10.1007\/s00296-012-2466-5","journal-title":"Rheumatol Int"},{"key":"4111_CR68","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/1756-185x.13262","volume":"21","author":"V Nair","year":"2018","unstructured":"Nair V, Vasdev V, Kumar A et al (2018) Stem cell transplant in systemic sclerosis: an Indian experience. Int J Rheum Dis 21:859\u2013865. https:\/\/doi.org\/10.1111\/1756-185x.13262","journal-title":"Int J Rheum Dis"},{"issue":"Suppl","key":"4111_CR69","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1016\/S0167-5273(96)88783-3","volume":"54","author":"BK Sharma","year":"1996","unstructured":"Sharma BK, Jain S, Suri S, Numano F (1996) Diagnostic criteria for Takayasu arteritis. Int J Cardiol 54(Suppl): S141\u2013S147","journal-title":"Int J Cardiol"},{"key":"4111_CR70","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1093\/rheumatology\/ket128","volume":"52","author":"R Misra","year":"2013","unstructured":"Misra R, Danda D, Rajappa SM et al (2013) Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010). Rheumatology 52:1795\u20131801. https:\/\/doi.org\/10.1093\/rheumatology\/ket128","journal-title":"Rheumatology"},{"key":"4111_CR71","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1093\/rheumatology\/ket289","volume":"52","author":"D Sinha","year":"2013","unstructured":"Sinha D, Mondal S, Nag A, Ghosh A (2013) Development of a colour Doppler ultrasound scoring system in patients of Takayasu\u2019s arteritis and its correlation with clinical activity score (ITAS 2010). Rheumatology 52:2196\u20132202. https:\/\/doi.org\/10.1093\/rheumatology\/ket289","journal-title":"Rheumatology"},{"key":"4111_CR72","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.semarthrit.2017.09.014","volume":"47","author":"R Goel","year":"2018","unstructured":"Goel R, Danda D, Joseph G et al (2018) Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: single centre experience from a large tertiary care teaching hospital in Southern India. Semin Arthritis Rheum 47:718\u2013726. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.09.014","journal-title":"Semin Arthritis Rheum"},{"key":"4111_CR73","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10067-009-1333-6","volume":"29","author":"R Goel","year":"2010","unstructured":"Goel R, Danda D, Mathew J, Edwin N (2010) Mycophenolate mofetil in Takayasu\u2019s arteritis. Clin Rheumatol 29:329\u2013332. https:\/\/doi.org\/10.1007\/s10067-009-1333-6","journal-title":"Clin Rheumatol"},{"key":"4111_CR74","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/1756-185x.12220","volume":"16","author":"R Goel","year":"2013","unstructured":"Goel R, Danda D, Kumar S, Joseph G (2013) Rapid control of disease activity by tocilizumab in 10 \u2018difficult-to-treat\u2019 cases of Takayasu arteritis. Int J Rheum Dis 16:754\u2013761. https:\/\/doi.org\/10.1111\/1756-185x.12220","journal-title":"Int J Rheum Dis"},{"key":"4111_CR75","first-page":"1793","volume":"30","author":"AK Valsakumar","year":"2003","unstructured":"Valsakumar AK, Valappil UC, Jorapur V et al (2003) Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu\u2019s arteritis. J Rheumatol 30:1793\u20131798","journal-title":"J Rheumatol"},{"key":"4111_CR76","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/0002-8703(92)90967-Z","volume":"124","author":"S Tyagi","year":"1992","unstructured":"Tyagi S, Kaul UA, Nair M et al (1992) Balloon angioplasty of the aorta in Takayasu\u2019s arteritis: initial and long-term results. Am Heart J 124:876\u2013882. https:\/\/doi.org\/10.1016\/0002-8703(92)90967-Z","journal-title":"Am Heart J"},{"key":"4111_CR77","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1148\/radiology.189.1.8103942","volume":"189","author":"SA Rao","year":"1993","unstructured":"Rao SA, Mandalam KR, Rao VR et al (1993) Takayasu arteritis: initial and long-term follow-up in 16 patients after percutaneous transluminal angioplasty of the descending thoracic and abdominal aorta. Radiology 189:173\u2013179. https:\/\/doi.org\/10.1148\/radiology.189.1.8103942","journal-title":"Radiology"},{"key":"4111_CR78","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s002709900248","volume":"21","author":"S Tyagi","year":"1998","unstructured":"Tyagi S, Verma PK, Gambhir DS et al (1998) Early and long-term results of subclavian angioplasty in aortoarteritis (Takayasu disease): comparison with atherosclerosis. Cardiovasc Interv Radiol 21:219\u2013224. https:\/\/doi.org\/10.1007\/s002709900248","journal-title":"Cardiovasc Interv Radiol"},{"key":"4111_CR79","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1016\/S0167-5273(00)00192-3","volume":"75","author":"BK Sharma","year":"2000","unstructured":"Sharma BK, Jain S, Bali HK, Jain A, Kumari S (2000) A follow-up study of balloon angioplasty and de-novo stenting in Takayasu arteritis. Int J Cardiol 75:S147\u2013S152. https:\/\/doi.org\/10.1016\/S0167-5273(00)00192-3","journal-title":"Int J Cardiol"},{"key":"4111_CR80","doi-asserted-by":"publisher","first-page":"681","DOI":"10.4103\/0028-3886.166543","volume":"63","author":"A Sharma","year":"2015","unstructured":"Sharma A, Sagar V, Prakash M et al (2015) Giant cell arteritis in India: report from a tertiary care center along with total published experience from India. Neurol India 63:681\u2013686. https:\/\/doi.org\/10.4103\/0028-3886.166543","journal-title":"Neurol India"},{"key":"4111_CR81","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/1756-185X.12954","volume":"20","author":"A Sharma","year":"2017","unstructured":"Sharma A, Pinto B, Dhooria A et al (2017) Polyarteritis nodosa in north India: clinical manifestations and outcomes. Int J Rheum Dis 20:390\u2013397. https:\/\/doi.org\/10.1111\/1756-185X.12954","journal-title":"Int J Rheum Dis"},{"key":"4111_CR82","first-page":"S134","volume":"34","author":"S Singh","year":"2016","unstructured":"Singh S, Sharma D, Suri DD et al (2016) Infliximab is the new kid on the block in Kawasaki disease: a single-centre study over 8 years from North India. Clin Exp Rheumatol 34:S134\u2013S138","journal-title":"Clin Exp Rheumatol"},{"key":"4111_CR83","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s11255-016-1330-z","volume":"48","author":"M Rathi","year":"2016","unstructured":"Rathi M, Pinto B, Dhooria A et al (2016) Impact of renal involvement on survival in ANCA-associated vasculitis. Int Urol Nephrol 48:1477\u20131482. https:\/\/doi.org\/10.1007\/s11255-016-1330-z","journal-title":"Int Urol Nephrol"},{"key":"4111_CR84","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4103\/0378-6323.107636","volume":"79","author":"A Singal","year":"2013","unstructured":"Singal A, Chhabra N, Pandhi D, Rohatgi J (2013) Behcet\u2019s disease in India: a dermatological perspective. Indian J Dermatol Venereol Leprol 79:199\u2013204. https:\/\/doi.org\/10.4103\/0378-6323.107636","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"4111_CR85","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3899\/jrheum.090937","volume":"37","author":"V Kunjir","year":"2010","unstructured":"Kunjir V, Venugopalan A, Chopra A (2010) Profile of Indian patients with juvenile onset chronic inflammatory joint disease using the ILAR classification criteria for JIA: a community-based cohort study. J Rheumatol 37:1756\u20131762. https:\/\/doi.org\/10.3899\/jrheum.090937","journal-title":"J Rheumatol"},{"key":"4111_CR86","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1002\/art.22709","volume":"56","author":"RK Saurenmann","year":"2007","unstructured":"Saurenmann RK, Rose JB, Tyrrell P et al (2007) Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. Arthritis Rheum 56:1974\u20131984. https:\/\/doi.org\/10.1002\/art.22709","journal-title":"Arthritis Rheum"},{"key":"4111_CR87","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/art.38092","volume":"65","author":"S Ringold","year":"2013","unstructured":"Ringold S, Weiss PF, Beukelman T et al (2013) 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Rheum 65:2499\u20132512. https:\/\/doi.org\/10.1002\/art.38092","journal-title":"Arthritis Rheum"},{"key":"4111_CR88","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10067-009-1277-x","volume":"29","author":"A Sharma","year":"2010","unstructured":"Sharma A, Kumar S, Wanchu A et al (2010) Clinical characteristics and predictors of mortality in 67 patients with primary pyomyositis: a study from North India. Clin Rheumatol 29:45\u201351. https:\/\/doi.org\/10.1007\/s10067-009-1277-x","journal-title":"Clin Rheumatol"},{"key":"4111_CR89","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1002\/art.23753","volume":"58","author":"A Chopra","year":"2008","unstructured":"Chopra A, Anuradha V, Lagoo-Joshi V et al (2008) Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum 58:2921\u20132922. https:\/\/doi.org\/10.1002\/art.23753","journal-title":"Arthritis Rheum"},{"key":"4111_CR90","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1017\/S0950268811001300","volume":"140","author":"A Chopra","year":"2012","unstructured":"Chopra A, Anuradha V, Ghorpade R, Saluja M (2012) Acute chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2-year prospective rural community study. Epidemiol Infect 140:842\u2013850. https:\/\/doi.org\/10.1017\/S0950268811001300","journal-title":"Epidemiol Infect"},{"key":"4111_CR91","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/art.38221","volume":"66","author":"A Chopra","year":"2014","unstructured":"Chopra A, Saluja M, Venugopalan A (2014) Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol 66:319\u2013326. https:\/\/doi.org\/10.1002\/art.38221","journal-title":"Arthritis Rheumatol"},{"key":"4111_CR92","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/S0973-3698(10)60189-6","volume":"4","author":"B Padmakumar","year":"2009","unstructured":"Padmakumar B, Jayan JB, Menon RMR et al (2009) Comparative evaluation of four therapeutic regimes in chikungunya arthritis: a prospective randomized parallel-group study. Indian J Rheumatol 4:94\u2013101. https:\/\/doi.org\/10.1016\/S0973-3698(10)60189-6","journal-title":"Indian J Rheumatol"},{"key":"4111_CR93","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0973-3698(10)60125-2","volume":"3","author":"S Pandya","year":"2008","unstructured":"Pandya S (2008) Methotrexate and hydroxychloroquine combination therapy in chronic chikungunya arthritis: a 16 week study. Indian J Rheumatol 3:93\u201397. https:\/\/doi.org\/10.1016\/S0973-3698(10)60125-2","journal-title":"Indian J Rheumatol"},{"key":"4111_CR94","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1007\/s10067-016-3429-0","volume":"36","author":"V Ravindran","year":"2017","unstructured":"Ravindran V, Alias G (2017) Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study. Clin Rheumatol 36:1335\u20131340. https:\/\/doi.org\/10.1007\/s10067-016-3429-0","journal-title":"Clin Rheumatol"},{"key":"4111_CR95","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1179\/1753615413Y.0000000016","volume":"35","author":"C De","year":"2013","unstructured":"De C, Mondal BC, Sinha RK et al (2013) A case series of 21 patients with non-osteoarticular tuberculosis of limbs. Int Musculoskelet Med 35:8\u201312. https:\/\/doi.org\/10.1179\/1753615413Y.0000000016","journal-title":"Int Musculoskelet Med"},{"key":"4111_CR96","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/injr.injr_38_17","volume":"12","author":"S Prasad","year":"2017","unstructured":"Prasad S, Wakhlu A, Misra R et al (2017) Features of extra-spinal musculoskeletal tuberculosis: a retrospective study from an North Indian Tertiary Care Institute. Indian J Rheumatol 12:146\u2013151. https:\/\/doi.org\/10.4103\/injr.injr_38_17","journal-title":"Indian J Rheumatol"},{"key":"4111_CR97","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/1756-185x.12726","volume":"19","author":"A Sharma","year":"2016","unstructured":"Sharma A, Pinto B, Dogra S et al (2016) A case series and review of Poncet\u2019s disease, and the utility of current diagnostic criteria. Int J Rheum Dis 19:1010\u20131017. https:\/\/doi.org\/10.1111\/1756-185x.12726","journal-title":"Int J Rheum Dis"},{"key":"4111_CR98","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0973-3698(11)60025-3","volume":"6","author":"RN Sarkar","year":"2011","unstructured":"Sarkar RN, Phaujdar S, Banerjee S et al (2011) Musculoskeletal involvement in leprosy. Indian J Rheumatol 6:20\u201324. https:\/\/doi.org\/10.1016\/S0973-3698(11)60025-3","journal-title":"Indian J Rheumatol"},{"key":"4111_CR99","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1756-185X.2012.01819.x","volume":"16","author":"S Prasad","year":"2013","unstructured":"Prasad S, Misra R, Aggarwal A et al (2013) Leprosy revealed in a rheumatology clinic: a case series. Int J Rheum Dis 16:129\u2013133. https:\/\/doi.org\/10.1111\/j.1756-185X.2012.01819.x","journal-title":"Int J Rheum Dis"},{"key":"4111_CR100","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s10067-013-2276-5","volume":"32","author":"S Salvi","year":"2013","unstructured":"Salvi S, Chopra A (2013) Leprosy in a rheumatology setting: a challenging mimic to expose. Clin Rheumatol 32:1557\u20131563. https:\/\/doi.org\/10.1007\/s10067-013-2276-5","journal-title":"Clin Rheumatol"},{"key":"4111_CR101","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/injr.injr_52_17","volume":"13","author":"A Wakhlu","year":"2018","unstructured":"Wakhlu A, Sawlani K, Himanshu D (2018) Rheumatological manifestations of Hansen\u2019s disease. Indian J Rheumatol 13:14\u201319. https:\/\/doi.org\/10.4103\/injr.injr_52_17","journal-title":"Indian J Rheumatol"},{"key":"4111_CR102","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/rheumatology\/kel367","volume":"46","author":"N Haroon","year":"2007","unstructured":"Haroon N, Agarwal V, Aggarwal A et al (2007) Arthritis as presenting manifestation of pure neuritic leprosy\u2014a rheumatologist\u2019s dilemma. Rheumatology 46:653\u2013656. https:\/\/doi.org\/10.1093\/rheumatology\/kel367","journal-title":"Rheumatology"},{"key":"4111_CR103","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJMc071552","volume":"357","author":"S Chauhan","year":"2007","unstructured":"Chauhan S, Agarwal V, D\u2019Cruz S (2007) Case 14-2007: a man with pain and swelling of both eyes and the right ear. N Engl J Med 357:621. https:\/\/doi.org\/10.1056\/NEJMc071552 author reply 621\u2013622.","journal-title":"N Engl J Med"},{"key":"4111_CR104","unstructured":"Global Leprosy Program\u2014Multi Drug Therapy (WHO). http:\/\/www.searo.who.int\/entity\/global_leprosy_programme\/mdt\/en\/. Accessed 05 Jun 2018"},{"key":"4111_CR105","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1086\/505222","volume":"43","author":"DM Scollard","year":"2006","unstructured":"Scollard DM, Joyce MP, Gillis TP (2006) Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases. Clin Infect Dis 43:e19\u2013e22. https:\/\/doi.org\/10.1086\/505222","journal-title":"Clin Infect Dis"},{"key":"4111_CR106","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.jbspin.2015.10.002","volume":"83","author":"F Verhoeven","year":"2016","unstructured":"Verhoeven F, Tordi N, Prati C et al (2016) Physical activity in patients with rheumatoid arthritis. Jt Bone Spine 83:265\u2013270. https:\/\/doi.org\/10.1016\/j.jbspin.2015.10.002","journal-title":"Jt Bone Spine"},{"key":"4111_CR107","unstructured":"Postgraduate training in physical medicine and rehabilitation in India. https:\/\/www.mciindia.org\/CMS\/information-desk\/college-and-course-search. Accessed 13 Jul 2018"},{"key":"4111_CR108","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0750-9","author":"R Compagnoni","year":"2018","unstructured":"Compagnoni R, Gualtierotti R, Randelli P (2018) Total joint arthroplasty in patients with inflammatory rheumatic diseases. Adv Ther. https:\/\/doi.org\/10.1007\/s12325-018-0750-9 (Epub ahead of print)","journal-title":"Adv Ther"},{"key":"4111_CR109","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.injr.2014.02.008","volume":"9","author":"R Handa","year":"2014","unstructured":"Handa R (2014) Rheumatology in postgraduate curriculum. Indian J Rheumatol 9:127\u2013130","journal-title":"Indian J Rheumatol"},{"key":"4111_CR110","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.injr.2014.04.001","volume":"9","author":"B Das","year":"2014","unstructured":"Das B (2014) Rheumatology in undergraduate curriculum. Indian J Rheumatol 9:69\u201372","journal-title":"Indian J Rheumatol"},{"key":"4111_CR111","unstructured":"Indian Government National Health programmes. https:\/\/www.nhp.gov.in\/healthprogramme\/national-health-programmes. Accessed 23 Apr 2018"},{"key":"4111_CR112","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S0973-3698(10)60373-1","volume":"3","author":"R Misra","year":"2008","unstructured":"Misra R, Sharma BL, Gupta R et al (2008) Indian Rheumatology Association consensus statement on the management of adults with rheumatoid arthritis. Indian J Rheumatol 3:S1\u2013S16. https:\/\/doi.org\/10.1016\/S0973-3698(10)60373-1","journal-title":"Indian J Rheumatol"},{"key":"4111_CR113","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0973-3698(10)60531-6","volume":"5","author":"AN Malaviya","year":"2010","unstructured":"Malaviya AN, Shankar S, Arya V et al (2010) Indian Rheumatology Association consensus statement on the diagnosis and treatment of axial spondyloarthropathies. Indian J Rheumatol 5:16\u201334. https:\/\/doi.org\/10.1016\/S0973-3698(10)60531-6","journal-title":"Indian J Rheumatol"},{"key":"4111_CR114","first-page":"80","volume":"10","author":"A Kumar","year":"2002","unstructured":"Kumar A (2002) Indian guidelines on the management of SLE. J Indian Rheumatol Assoc 10:80\u201396","journal-title":"J Indian Rheumatol Assoc"},{"key":"4111_CR115","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0973-3698(11)60060-5","volume":"6","author":"V Krishnamurthy","year":"2011","unstructured":"Krishnamurthy V, Sharma A, Aggarwal A et al (2011) Indian rheumatology association guidelines for management of glucocorticoid-induced osteoporosis. Indian J Rheumatol 6:68\u201375. https:\/\/doi.org\/10.1016\/S0973-3698(11)60060-5","journal-title":"Indian J Rheumatol"},{"key":"4111_CR116","doi-asserted-by":"publisher","first-page":"600","DOI":"10.3325\/cmj.2013.54.600","volume":"54","author":"AY Gasparyan","year":"2013","unstructured":"Gasparyan AY, Ayvazyan L, Akazhanov NA, Kitas GD (2013) Conflicts of interest in biomedical publications: considerations for authors, peer reviewers, and editors. Croat Med J 54:600\u2013608. https:\/\/doi.org\/10.3325\/cmj.2013.54.600","journal-title":"Croat Med J"},{"key":"4111_CR117","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1136\/annrheumdis-2014-206350","volume":"74","author":"D van der Heijde","year":"2015","unstructured":"van der Heijde D, Aletaha D, Carmona L et al (2015) 2014 update of the EULAR standardised operating procedures for EULAR-endorsed recommendations. Ann Rheum Dis 74:8\u201313. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206350","journal-title":"Ann Rheum Dis"},{"key":"4111_CR118","unstructured":"(2016) Indian J Rheumatol 11:S1\u2013S108"},{"key":"4111_CR119","unstructured":"(2017) Indian J Rheumatol 12:S1\u2013S132"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-018-4111-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4111-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-018-4111-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T16:39:50Z","timestamp":1659112790000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-018-4111-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,19]]},"references-count":119,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4111"],"URL":"https:\/\/doi.org\/10.1007\/s00296-018-4111-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,19]]},"assertion":[{"value":"24 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Durga Prasanna Misra declares that he has no conflict of interest, including no relationship with pharmaceutical companies. Aman Sharma declares that he has no conflict of interest, including no relationship with pharmaceutical companies. Vikas Agarwal declares that he has no conflict of interest, including no relationship with pharmaceutical companies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}